Unpacking Palantir's Soaring Market Valuation
Insights from GMO's Investment Performance and Strategy
GMO, a prominent investment management entity, recently disseminated its comprehensive year-end letter for 2025. The firm expressed satisfaction with the long-term efficacy of its market-neutral strategy. This approach aims to capitalize on significant valuation discrepancies between value-oriented and growth-oriented stocks. In 2025, the strategy yielded a gross return of 15.8% (13.4% net). Since its inception, it has accumulated a gross return of 69.3% (50.6% net), maintaining a substantial valuation gap. This success is attributed to diligent stock selection, an advanced proprietary valuation model, and stringent risk management protocols. The top five holdings of this portfolio offer further insights into its most successful investments for the year.
Palantir Technologies: A Deep Dive into its Market Metrics
In its fourth-quarter 2025 investor letter, GMO specifically spotlighted Palantir Technologies Inc. (NASDAQ:PLTR). Palantir specializes in developing and deploying sophisticated software platforms that assist the intelligence community in counterterrorism investigations and operations. As of March 31, 2026, Palantir Technologies Inc. (NASDAQ:PLTR) closed at a share price of $146.28. While its shares experienced a -4.51% decline over the preceding month, they recorded an impressive 67.27% gain over the past 52 weeks. The company commands a substantial market capitalization of $349.854 billion.
GMO's Perspective on Palantir's Valuation Anomaly
GMO offered a noteworthy commentary on Palantir Technologies Inc. (NASDAQ:PLTR) in its investor letter. The firm noted that the other eight U.S. Information Technology stocks held short by GMO delivered an average performance exceeding 63%. Palantir Technologies Inc., however, stood out as the single largest detractor from absolute returns at the portfolio level, surging by an astonishing 135% for the year. This remarkable growth has led to what GMO describes as a "somewhat bewildering" price/sales ratio well over 100. GMO maintains optimism for its Equity Dislocation Strategy, believing that numerous stocks continue to ride a wave of speculative excess.
Palantir's Presence in Hedge Fund Portfolios and Future Prospects
Despite its significant market presence, Palantir Technologies Inc. (NASDAQ:PLTR) does not feature on our curated list of the 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. Data from our database indicates that 89 hedge fund portfolios included Palantir Technologies Inc. (NASDAQ:PLTR) at the close of the fourth quarter, an increase from 81 in the prior quarter. While acknowledging Palantir's investment potential, we posit that certain artificial intelligence (AI) stocks present more substantial upside opportunities with reduced downside risk. For those seeking an exceptionally undervalued AI stock poised to benefit from Trump-era tariffs and the ongoing onshoring trend, a specialized report on the best short-term AI stock is available.